UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
79 hedge funds and large institutions have $157M invested in Unity Biotechnology in 2019 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 34 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.96% more ownership
Funds ownership: 3.78% → 4.74% (+0.96%)
50% less call options, than puts
Call options by funds: $2K | Put options by funds: $4K
Holders
79
Holding in Top 10
2
Calls
$2K
Puts
$4K
Top Buyers
| 1 | +$2.43M | |
| 2 | +$1.5M | |
| 3 | +$1.35M | |
| 4 |
BlackRock
New York
|
+$1.06M |
| 5 |
Morgan Stanley
New York
|
+$1.05M |
Top Sellers
| 1 | -$314K | |
| 2 | -$117K | |
| 3 | -$84K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$37.9K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$24.1K |